Prelude Therapeutics Stock Price History
| PRLD Stock | USD 0.74 0 0.41% |
Below is the normalized historical share price chart for Prelude Therapeutics extending back to September 25, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Prelude Therapeutics stands at 0.74, as last reported on the 21st of March, with the highest price reaching 0.74 and the lowest price hitting 0.74 during the day.
If you're considering investing in Prelude Stock, it is important to understand the factors that can impact its price. Prelude Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of -0.11, which implies the firm had a -0.11 % return per unit of risk over the last 3 months. Prelude Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Prelude Therapeutics' Coefficient Of Variation of (21,296), risk adjusted performance of 0.0048, and Variance of 73.0 to confirm the risk estimate we provide.
At present, Prelude Therapeutics' Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting. . At present, Prelude Therapeutics' Price Earnings To Growth Ratio is projected to increase slightly based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 0.77, whereas Price Earnings Ratio is forecasted to decline to (0.79). Prelude Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 25th of September 2020 | 200 Day MA 2.5398 | 50 Day MA 0.9513 | Beta 1.42 |
Prelude |
Sharpe Ratio = -0.1096
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | PRLD |
Estimated Market Risk
| 6.26 actual daily | 55 55% of assets are less volatile |
Expected Return
| -0.69 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Prelude Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Prelude Therapeutics by adding Prelude Therapeutics to a well-diversified portfolio.
Price Book 0.3093 | Enterprise Value Ebitda (0.54) | Price Sales 5.8086 | Shares Float 17.7 M | Wall Street Target Price 3.3333 |
Prelude Therapeutics Stock Price History Chart
There are several ways to analyze Prelude Stock price data. The simplest method is using a basic Prelude candlestick price chart, which shows Prelude Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | December 26, 2024 | 1.4 |
| Lowest Price | March 11, 2025 | 0.66 |
Prelude Therapeutics March 21, 2025 Stock Price Synopsis
Various analyses of Prelude Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Prelude Stock. It can be used to describe the percentage change in the price of Prelude Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Prelude Stock.| Prelude Therapeutics Price Rate Of Daily Change | 1.00 |
Prelude Therapeutics March 21, 2025 Stock Price Analysis
Prelude Stock Price History Data
The price series of Prelude Therapeutics for the period between Sat, Dec 21, 2024 and Fri, Mar 21, 2025 has a statistical range of 0.74 with a coefficient of variation of 20.67. The price distribution for the period has arithmetic mean of 0.99. The median price for the last 90 days is 1.01.| Open | High | Low | Close | Volume | ||
03/21/2025 | 0.74 | 0.74 | 0.74 | 0.74 | ||
03/21/2025 | 0.74 | 0.80 | 0.70 | 0.74 | ||
| 03/19/2025 | 0.71 | 0.80 | 0.70 | 0.74 | 84,188 | |
| 03/18/2025 | 0.75 | 0.75 | 0.70 | 0.71 | 64,231 | |
| 03/17/2025 | 0.75 | 0.80 | 0.74 | 0.75 | 186,646 | |
| 03/14/2025 | 0.75 | 0.79 | 0.74 | 0.74 | 301,278 | |
| 03/13/2025 | 0.70 | 0.80 | 0.68 | 0.71 | 165,353 | |
| 03/12/2025 | 0.71 | 0.76 | 0.69 | 0.70 | 259,318 | |
| 03/11/2025 | 0.67 | 0.86 | 0.66 | 0.66 | 188,994 | |
| 03/10/2025 | 0.72 | 0.76 | 0.67 | 0.67 | 203,320 | |
| 03/07/2025 | 0.71 | 0.76 | 0.71 | 0.74 | 81,669 | |
| 03/06/2025 | 0.74 | 0.76 | 0.71 | 0.71 | 73,440 | |
| 03/05/2025 | 0.75 | 0.77 | 0.70 | 0.76 | 86,427 | |
| 03/04/2025 | 0.68 | 0.75 | 0.67 | 0.74 | 110,780 | |
| 03/03/2025 | 0.74 | 0.77 | 0.67 | 0.68 | 254,457 | |
| 02/28/2025 | 0.75 | 0.78 | 0.73 | 0.76 | 174,754 | |
| 02/27/2025 | 0.81 | 0.83 | 0.74 | 0.75 | 243,909 | |
| 02/26/2025 | 0.81 | 0.84 | 0.81 | 0.81 | 146,825 | |
| 02/25/2025 | 0.83 | 0.85 | 0.81 | 0.81 | 183,642 | |
| 02/24/2025 | 0.88 | 0.91 | 0.83 | 0.83 | 100,308 | |
| 02/21/2025 | 0.93 | 0.93 | 0.87 | 0.87 | 161,152 | |
| 02/20/2025 | 0.91 | 0.95 | 0.87 | 0.90 | 167,023 | |
| 02/19/2025 | 0.95 | 0.98 | 0.89 | 0.90 | 183,009 | |
| 02/18/2025 | 0.99 | 0.99 | 0.93 | 0.95 | 202,770 | |
| 02/14/2025 | 0.94 | 1.01 | 0.94 | 0.97 | 169,677 | |
| 02/13/2025 | 0.94 | 0.96 | 0.91 | 0.95 | 148,455 | |
| 02/12/2025 | 0.91 | 0.97 | 0.90 | 0.91 | 211,126 | |
| 02/11/2025 | 1.08 | 1.08 | 0.92 | 0.92 | 283,814 | |
| 02/10/2025 | 1.04 | 1.09 | 0.98 | 1.09 | 691,077 | |
| 02/07/2025 | 1.10 | 1.13 | 1.00 | 1.01 | 262,964 | |
| 02/06/2025 | 1.17 | 1.19 | 1.10 | 1.11 | 106,199 | |
| 02/05/2025 | 1.12 | 1.19 | 1.10 | 1.17 | 218,966 | |
| 02/04/2025 | 1.11 | 1.14 | 1.09 | 1.11 | 74,517 | |
| 02/03/2025 | 1.10 | 1.13 | 1.07 | 1.11 | 65,165 | |
| 01/31/2025 | 1.20 | 1.20 | 1.10 | 1.10 | 268,239 | |
| 01/30/2025 | 1.15 | 1.22 | 1.10 | 1.19 | 141,030 | |
| 01/29/2025 | 1.13 | 1.20 | 1.08 | 1.15 | 156,901 | |
| 01/28/2025 | 1.12 | 1.14 | 1.06 | 1.14 | 129,931 | |
| 01/27/2025 | 1.22 | 1.22 | 1.12 | 1.13 | 125,985 | |
| 01/24/2025 | 1.15 | 1.27 | 1.13 | 1.22 | 240,787 | |
| 01/23/2025 | 1.13 | 1.18 | 1.05 | 1.14 | 171,478 | |
| 01/22/2025 | 1.22 | 1.31 | 1.15 | 1.17 | 333,949 | |
| 01/21/2025 | 1.06 | 1.30 | 1.05 | 1.22 | 901,100 | |
| 01/17/2025 | 1.00 | 1.06 | 0.99 | 1.05 | 147,785 | |
| 01/16/2025 | 1.06 | 1.06 | 0.99 | 1.02 | 232,968 | |
| 01/15/2025 | 1.02 | 1.05 | 1.01 | 1.03 | 83,259 | |
| 01/14/2025 | 1.03 | 1.07 | 1.00 | 1.02 | 137,794 | |
| 01/13/2025 | 1.08 | 1.08 | 0.98 | 1.03 | 397,642 | |
| 01/10/2025 | 1.13 | 1.16 | 1.03 | 1.06 | 327,253 | |
| 01/08/2025 | 1.21 | 1.26 | 1.13 | 1.14 | 243,142 | |
| 01/07/2025 | 1.31 | 1.33 | 1.15 | 1.21 | 280,983 | |
| 01/06/2025 | 1.38 | 1.43 | 1.29 | 1.33 | 271,312 | |
| 01/03/2025 | 1.40 | 1.41 | 1.30 | 1.39 | 455,999 | |
| 01/02/2025 | 1.28 | 1.29 | 1.21 | 1.25 | 313,373 | |
| 12/31/2024 | 1.25 | 1.34 | 1.17 | 1.27 | 616,198 | |
| 12/30/2024 | 1.34 | 1.38 | 1.12 | 1.21 | 919,036 | |
| 12/27/2024 | 1.41 | 1.48 | 1.33 | 1.34 | 442,745 | |
| 12/26/2024 | 1.30 | 1.41 | 1.27 | 1.40 | 430,455 | |
| 12/24/2024 | 1.22 | 1.24 | 1.14 | 1.19 | 218,009 | |
| 12/23/2024 | 1.31 | 1.59 | 1.15 | 1.24 | 1,433,548 | |
| 12/20/2024 | 0.94 | 1.45 | 0.94 | 1.30 | 4,441,321 |
About Prelude Therapeutics Stock history
Prelude Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Prelude is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Prelude Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Prelude Therapeutics stock prices may prove useful in developing a viable investing in Prelude Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 75.8 M | 53.3 M | |
| Net Loss | -103.9 M | -109.1 M |
Prelude Therapeutics Quarterly Net Working Capital |
|
Prelude Therapeutics Stock Technical Analysis
Prelude Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Holdings Now
Portfolio HoldingsCheck your current holdings and cash postion to detemine if your portfolio needs rebalancing |
| All Next | Launch Module |
Prelude Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Prelude Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Prelude Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Prelude to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0048 | |||
| Jensen Alpha | 0.1339 | |||
| Total Risk Alpha | 0.6712 | |||
| Treynor Ratio | (0.02) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Prelude Stock analysis
When running Prelude Therapeutics' price analysis, check to measure Prelude Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Prelude Therapeutics is operating at the current time. Most of Prelude Therapeutics' value examination focuses on studying past and present price action to predict the probability of Prelude Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Prelude Therapeutics' price. Additionally, you may evaluate how the addition of Prelude Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |